Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Sea Limited
SE
$75.5B
| $11M | ﹤0.01% |
34,500
+27,790
| +414% | +$8.53M |
|
|
BRKL
1952
DELISTED
Brookline Bancorp
BRKL
| $11M | ﹤0.01% |
719,047
+9,272
| +1% | +$135K |
|
1953
Vanda Pharmaceuticals
VNDA
$304M
| $11M | ﹤0.01% |
639,882
+84,975
| +15% | +$1.49M |
|
1954
Valaris
VAL
$5.91B
| $10.9M | ﹤0.01% |
+313,895
| New | +$9.02M |
|
|
HA
1955
DELISTED
Hawaiian Holdings, Inc.
HA
| $10.9M | ﹤0.01% |
503,175
+6,408
| +1% | +$131K |
|
1956
National Healthcare
NHC
$3.44B
| $10.9M | ﹤0.01% |
155,422
+11,394
| +8% | +$829K |
|
|
PRTY
1957
DELISTED
Party City Holdco Inc.
PRTY
| $10.9M | ﹤0.01% |
1,531,672
-204,720
| -12% | -$1.56M |
|
1958
Interparfums
IPAR
$3.7B
| $10.9M | ﹤0.01% |
145,380
+9,731
| +7% | +$711K |
|
1959
Core Laboratories
CLB
$569M
| $10.8M | ﹤0.01% |
390,857
-11,612
| -3% | -$353K |
|
1960
Rocket Companies
RKT
$42.6B
| $10.8M | ﹤0.01% |
674,297
+6,949
| +1% | +$121K |
|
1961
Levi Strauss
LEVI
$8.63B
| $10.8M | ﹤0.01% |
440,934
+41,455
| +10% | +$1.12M |
|
1962
Mesa Laboratories
MLAB
$633M
| $10.8M | ﹤0.01% |
35,721
+2,148
| +6% | +$611K |
|
1963
National Beverage
FIZZ
$2.93B
| $10.8M | ﹤0.01% |
204,925
+10,530
| +5% | +$490K |
|
1964
Cohu
COHU
$2.76B
| $10.8M | ﹤0.01% |
336,635
+4,147
| +1% | +$141K |
|
1965
Liberty Broadband Class A
LBRDA
$5.29B
| $10.7M | ﹤0.01% |
63,790
+4,505
| +8% | +$787K |
|
1966
CNA Financial
CNA
$13.8B
| $10.7M | ﹤0.01% |
255,385
+8,646
| +4% | +$378K |
|
1967
Chefs' Warehouse
CHEF
$4.57B
| $10.7M | ﹤0.01% |
328,632
-2,120
| -0.6% | -$62.2K |
|
1968
Adtran
ADTN
$658M
| $10.7M | ﹤0.01% |
569,529
-24,659
| -4% | -$519K |
|
1969
CoreCivic
CXW
$3.13B
| $10.7M | ﹤0.01% |
1,200,359
-26,622
| -2% | -$259K |
|
|
INVX
1970
Innovex International
INVX
$2.15B
| $10.7M | ﹤0.01% |
424,243
+24,938
| +6% | +$663K |
|
1971
Bionano Genomics
BNGO
$13.5M
| $10.7M | ﹤0.01% |
3,237
+2,069
| +177% | +$7.24M |
|
1972
Butterfly Network
BFLY
$2.36B
| $10.7M | ﹤0.01% |
1,021,543
+337,723
| +49% | +$3.9M |
|
|
DENN
1973
DELISTED
Denny's
DENN
| $10.7M | ﹤0.01% |
652,517
+18,264
| +3% | +$287K |
|
1974
First Busey Corp
BUSE
$2.58B
| $10.7M | ﹤0.01% |
432,704
+42,155
| +11% | +$996K |
|
1975
Check Point Software Technologies
CHKP
$13.7B
| $10.6M | ﹤0.01% |
94,117
+3,968
| +4% | +$483K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.